Janney Capital Management LLC Acquires New Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Janney Capital Management LLC bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 10,561 shares of the company's stock, valued at approximately $369,000.

Several other institutional investors and hedge funds also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the 4th quarter valued at $26,000. Signaturefd LLC raised its holdings in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its holdings in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in Option Care Health during the 4th quarter worth about $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Trading Down 1.5%

Shares of OPCH stock traded down $0.48 on Monday, reaching $31.05. The company had a trading volume of 1,865,840 shares, compared to its average volume of 1,879,989. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The stock has a market cap of $5.08 billion, a PE ratio of 25.04, a PEG ratio of 1.90 and a beta of 0.74. The company has a 50-day moving average of $32.06 and a 200-day moving average of $30.69. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. Option Care Health's revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.26 EPS. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have weighed in on OPCH shares. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Wednesday, June 18th. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.